Low‐Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real‐World Study
Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 395-401
DOI: 10.1002/ccd.70662 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, published online on 2026-05-22. Written by Ecem Gürses and 9 co-authors. Institution: Department of Cardiology, Bakırçay University Çiğli Training and Research Hospital, İzmir, Turkey. Major MEDLINE topics: Colchicine, Secondary Prevention, Angina Pectoris, Cardiovascular Agents. 23 references. The full text is freely available in PubMed Central.
Abstract (original language)
Aims
Chronic coronary syndrome (CCS) remains associated with recurrent ischemic symptoms and impaired quality of life despite contemporary guideline‐directed medical therapy. Low‐dose colchicine has demonstrated prognostic benefits in randomized trials; however, real‐world data regarding its effects on functional capacity and angina‐related outcomes are limited.
Methods
This multicenter, real‐world observational study included 614 patients with CCS receiving low‐dose colchicine therapy for secondary prevention. Functional capacity and angina‐related quality of life were assessed before and after colchicine treatment using the Seattle Angina Questionnaire. Changes in daily physical activities, angina frequency, nitroglycerin use, treatment satisfaction, and Canadian Cardiovascular Society (CCS) angina class were evaluated. Clinical outcomes and tolerability, including hospitalization, revascularization, and gastrointestinal adverse effects, were also analyzed. A clinically meaningful improvement was defined as a ≥ 10‐point increase in the composite Seattle Angina Questionnaire score.
Results
The mean age of the study population was 68.8 ± 11.5 years, and 70.5% of patients were male. Following colchicine therapy, significant improvements were observed in functional capacity, including walking on level ground, household activities, and carrying heavy objects (all p < 0.001). Angina frequency scores improved, accompanied by reduced nitroglycerin use ( p < 0.001). Treatment satisfaction increased and limitations in enjoyment of life decreased significantly ( p < 0.001). CCS angina class decreased from 2.61 ± 0.7 to 1.4 ± 0.62 ( p < 0.001). A clinically meaningful improvement in SAQ score was observed in 78.7% of patients. During follow‐up, hospitalization occurred in 9.0% of patients, revascularization in 4.4%, and gastrointestinal adverse effects were reported in 9.4%.
Conclusions
In a multicenter real‐world cohort of patients with chronic coronary syndrome, low‐dose colchicine therapy was associated with significant improvements in functional capacity, angina severity, and quality of life, with an acceptable safety profile. The high rate of clinically meaningful patient‐reported improvement further supports colchicine as an effective adjunctive therapy for secondary prevention and symptom control in routine clinical practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Bakırçay University Çiğli Training and Research Hospital, İzmir, Turkey.
- Department of Cardiology, Izmir University of Economics, Medical Point Hospital, İzmir, Turkey.
- Ödemiş State Hospital, İzmir, Turkey.
- Istanbul Training and Research Hospital, İstanbul, Turkey.
- Department of Cardiology, Ege University, Izmir, Turkey.
- Department of Cardiology, Izmir City Hospital, Izmir, Turkey.
ORCID profiles: Ecem Gürses, Umut Uyan, Ahmet Öz, İlker Gül
Cite
APA
Gürses, E., Doğduş, M., Uyan, U., Öz, A., Javadova, S., İlhan, G. N. D., Çabuk, G., Sivri, F., Zoghi, M., & Gül, İ. (2026). Low‐Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real‐World Study. Catheterization and Cardiovascular Interventions, 108(2), 395-401. https://doi.org/10.1002/ccd.70662
Vancouver
Gürses E, Doğduş M, Uyan U, Öz A, Javadova S, İlhan GND, et al. Low‐Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real‐World Study. Catheterization and Cardiovascular Interventions. 2026;108(2):395-401. doi:10.1002/ccd.70662
BibTeX
@article{Grses2026,
author = {Gürses, Ecem and Doğduş, Mustafa and Uyan, Umut and Öz, Ahmet and Javadova, Shabnam and İlhan, Gökçe Nur Durmuş and Çabuk, Gizem and Sivri, Fatih and Zoghi, Mehdi and Gül, İlker},
title = {Low‐Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real‐World Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {2},
pages = {395--401},
doi = {10.1002/ccd.70662}
}
EUVIMED